» Articles » PMID: 39459029

New Quinazolin-4(3H)-One Derivatives Incorporating Isoxazole Moiety As Antioxidant Agents: Synthesis, Structural Characterization, and Theoretical DFT Mechanistic Study

Abstract

: This research centers on the development and spectroscopic characterization of new quinazolin-4(3H)-one-isoxazole derivatives (). The aim was to investigate the regioselectivity of the 1,3-dipolar cycloaddition involving arylnitriloxides and N-propargylquinazolin-4(3H)-one, and to assess the antioxidant properties of the synthesized compounds. The synthetic approach started with the alkylation of quinazolin-4(3H)-one using propargyl bromide, followed by a 1,3-dipolar cycloaddition reaction. : The structural identification of the products was performed using various spectroscopic methods, such as IR, 1H, 13C, and HMBC NMR, HRMS, and single-crystal X-ray diffraction. To further examine the regioselectivity of the cycloaddition, Density Functional Theory (DFT) calculations at the B3LYP/6-31G(d) level were employed. Additionally, the antioxidant potential of the compounds was tested in vitro using DPPH (2,2-Diphenyl-1-picrylhydrazyl)radical scavenging assays. The reaction selectively produced 3,5-disubstituted isoxazoles, with the regiochemical outcome being independent of the substituents on the phenyl ring. : Theoretical calculations using DFT were in agreement with the experimental results, revealing activation energies of -81.15 kcal/mol for P-1 and -77.32 kcal/mol for P-2, favoring the formation of P-1. An analysis of the Intrinsic Reaction Coordinate (IRC) confirmed that the reaction proceeded via a concerted but asynchronous mechanism. The antioxidant tests demonstrated that the synthesized compounds exhibited significant radical scavenging activity, as shown in the DPPH assay. The 1,3-dipolar cycloaddition of arylnitriloxides with N-propargylquinazolin-4(3H)-one successfully resulted in novel 3,5-disubstituted isoxazoles. : The experimental findings were well-supported by theoretical predictions, and the antioxidant assays revealed strong activity, indicating the potential for future biological applications of these compounds.

References
1.
Pawelczyk A, Sowa-Kasprzak K, Olender D, Zaprutko L . Molecular Consortia-Various Structural and Synthetic Concepts for More Effective Therapeutics Synthesis. Int J Mol Sci. 2018; 19(4). PMC: 5979569. DOI: 10.3390/ijms19041104. View

2.
Ayers P, Parr R, Pearson R . Elucidating the hard/soft acid/base principle: a perspective based on half-reactions. J Chem Phys. 2006; 124(19):194107. DOI: 10.1063/1.2196882. View

3.
Singh H, Kumar M, Nepali K, Gupta M, Saxena A, Sharma S . Triazole tethered C5-curcuminoid-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies. Eur J Med Chem. 2016; 116:102-115. DOI: 10.1016/j.ejmech.2016.03.050. View

4.
Wang J, Wang X, Wang Y, Tang W, Shi J, Liu X . Novel curcumin analogue hybrids: Synthesis and anticancer activity. Eur J Med Chem. 2018; 156:493-509. DOI: 10.1016/j.ejmech.2018.07.013. View

5.
El-Sayed A, Ismail M, Amr A, Naglah A . Synthesis, Antiproliferative, and Antioxidant Evaluation of 2-Pentylquinazolin-4(3)-one(thione) Derivatives with DFT Study. Molecules. 2019; 24(20). PMC: 6832655. DOI: 10.3390/molecules24203787. View